Home » Canada Plans New Submission Route for Extraordinary-Use New Drugs
Canada Plans New Submission Route for Extraordinary-Use New Drugs
May 18, 2010
Manufacturers of new drugs developed to meet health emergencies may soon have a distinct route to approval of their products in Canada. Includes the full text of Health Canada Plan For Extraordinary Use New Drugs.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor